Subsequently, it was further shown that the senescence phenotype driven by excessive DNMT expression observed in amyotrophic lateral sclerosis (ALS) could be mitigated by RG108 treatment [126]. Here, DNMT1 is linked to amyotrophic lateral sclerosis.